Company intelligence / Profile preview

Arevipharma

Radebeul, Saxony, Germanyarevipharma.com ↗

Ownership: Private
Employees: ~191
Development stage: Commercial

Overview

Arevipharma operates as a fully integrated manufacturer of active pharmaceutical ingredients with over a century of experience, supplying more than forty different APIs globally for pain management, CNS disorders, cardiovascular disease, and other therapeutic areas. The company specializes in the production and handling of controlled substances under strict regulatory compliance.

Therapeutic areas: OtherCardiovascularNeurology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Works with generic and research-based pharmaceutical companies worldwide as contract manufacturing partner

Beyond the preview

Go deeper on Arevipharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arevipharma.

Explore the full profile